Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Conditions: Liver Transplant; Hepatocellular Carcinoma Recurrent; Systemic Treatment Interventions: Drug: Systemic therapy Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Observational Study Protocol: LIVER-R
Conditions: Hepatobiliary Cancers Interventions: Other: Durvalumab-based combination therapies in observational study setting; Other: Durvalumab-based combination therapies in observational study setting Sponsors: AstraZeneca; ICON plc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Generation of Organotypic Liver Cultures for the Identification of Biomarkers for the Prevention and Treatment of Liver Fibrosis
Conditions: Hepatic Fibrosis Interventions: Diagnostic Test: Biopsy from patients undergoing surgery abdominal. Sponsors: Regina Elena Cancer Institute; Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver Cancer
Conditions: Liver Cancer Interventions: Drug: QY-1-T Sponsors: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Zhongke Qiyuan (Shenzhen) Biotechnology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Contained Hepatic Vascular Injuries Following Liver Trauma
Conditions: Hepatic Injury; Liver Injury; Pseudoaneurysm Sponsors: Centre Hospitalier Universitaire de Nice Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Weight Loss and Physical Activity Lifestyle Interventions In Post Liver And Kidney Transplants
Conditions: Weight Loss; Lifestyle Factors Interventions: Device: Wrist activity tracker and scale; Behavioral: Nutritional Coaching group sessions Sponsors: Massachusetts General Hospital; American Society of Transplantation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
Conditions: Hepatocellular Carcinoma Interventions: Procedure: Liver resection; Procedure: Locoregional therapy Sponsors: Chen Xiaoping Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Find HDV and Determine Its Status in Turkey
Conditions: Chronic Hepatitis D Infection With Hepatitis B Carrier State (Diagnosis); Fibrosis, Liver; Hepatocellular Carcinoma; Cirrhosis, Liver; Transmission Vertical Interventions: Diagnostic Test: Anti Delta Sponsors: Yasar Bay ındır; SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
Conditions: Hepatic Cancer Interventions: Procedure: transarterial chemoembolisation Sponsors: Tang-Du Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.
Conditions: Decompensated Cirrhosis Interventions: Drug: Albumin; Drug: Midodrine; Other: Standard of Care Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
Conditions: Hepatic Carcinoma Interventions: Procedure: transarterial chemoembolisation Sponsors: Tang-Du Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation
Conditions: Hypercholesterolemia Interventions: Dietary Supplement: Dietary Supplement; Other: Placebo Sponsors: University of Bologna Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy
Conditions: Hyperthermic Intraperitoneal Chemotherapy; Hepatocellular Carcinoma; Ruptured Liver Interventions: Procedure: intraperitoneal hyperthermic perfusion chemotherapy Sponsors: Zhujiang Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors
Conditions: Non-alcoholic Fatty Liver Disease; Liver Fibrosis; Liver Injury Interventions: Drug: Ganwei; Drug: Metformin; Drug: Placebo Sponsors: Taipei City Hospital; The One Biopharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.
Conditions: Advanced Hepatocellular Carcinoma Interventions: Other: No intervention Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
